Drug Clinical Trials Research
Clinical trial data for 100 drugs under active research. See drug-by-drug comparison pages →
Palynziq
Palynziq clinical trials: 2 studies for Phenylketonuria and Phenylketonurias, 1 recruiting. Side effects, dosing, and results from completed trials.
Naporafenib
Naporafenib clinical trials: 2 studies for Advanced or Metastatic NRAS-mutant Melanoma and Advanced or Metastatic Solid Tumors. Side effects, dosing, and res...
REGN7075
REGN7075 clinical trials: 5 studies for Advanced Solid Tumors and Advanced/Metastatic Non-Small Cell Lung Cancer, 4 recruiting. Side effects, dosing, and res...
HDM1005
HDM1005 clinical trials: 10 studies for Obesity and Type 2 Diabetes, 5 recruiting. Side effects, dosing, and results from completed trials.
Apremilast
Apremilast clinical trials: 137 studies for Psoriasis and Psoriatic Arthritis, 13 recruiting. Side effects, dosing, and results from completed trials.
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir clinical trials: 40 studies for Hepatitis C and Hepatitis C Virus (HCV), 3 recruiting. Side effects, dosing, and results from comple...
Azirkitug
Azirkitug clinical trials: 1 studies for Gastric/Esophageal Cancer and Head and Neck Squamous Cell Carcinoma, 1 recruiting. Side effects, dosing, and results...
Tuspetinib
Tuspetinib clinical trials: 1 studies for Chronic Myelomonocytic Leukemia and Leukemia, Myeloid, Acute, 1 recruiting. Side effects, dosing, and results from ...
MRTX1719
MRTX1719 clinical trials: 2 studies for Solid Tumor and Advanced Solid Tumor, 2 recruiting. Side effects, dosing, and results from completed trials.
Surabgene Lomparvovec
Surabgene Lomparvovec clinical trials: 2 studies for Diabetic Retinopathy and Neovascular Age-related Macular Degeneration, 2 recruiting. Side effects, dosin...
Gocatamig
Gocatamig clinical trials: 3 studies for Neuroendocrine Carcinoma and Small-Cell Lung Cancer, 2 recruiting. Side effects, dosing, and results from completed ...
IMNN-001
IMNN-001 clinical trials: 4 studies for Fallopian Tube Cancer and Epithelial Ovarian Cancer, 2 recruiting. Side effects, dosing, and results from completed t...
Iadademstat
Iadademstat clinical trials: 8 studies for Acute Myeloid Leukemia and Acute Myeloid Leukemia Refractory, 5 recruiting. Side effects, dosing, and results from...
Bimagrumab
Bimagrumab clinical trials: 11 studies for Obesity and Sarcopenia, 1 recruiting. Side effects, dosing, and results from completed trials.
Etentamig
Etentamig clinical trials: 11 studies for Multiple Myeloma and Relapsed/Refractory Multiple Myeloma, 6 recruiting. Side effects, dosing, and results from com...
Golcadomide
Golcadomide clinical trials: 15 studies for Refractory Primary Mediastinal Large B-Cell Lymphoma and Large B-cell Lymphoma, 7 recruiting. Side effects, dosin...
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir clinical trials: 38 studies for Hepatitis C and Hepatitis C Virus (HCV), 3 recruiting. Side effects, dosing, and results from comple...
Retifanlimab
Retifanlimab clinical trials: 56 studies for Breast Cancer and Merkel Cell Carcinoma, 16 recruiting. Side effects, dosing, and results from completed trials.
Polatuzumab Vedotin
Polatuzumab Vedotin clinical trials: 80 studies for Diffuse Large B-Cell Lymphoma and Diffuse Large B Cell Lymphoma, 30 recruiting. Side effects, dosing, and...
Dostarlimab
Dostarlimab clinical trials: 87 studies for Neoplasms and Endometrial Cancer, 29 recruiting. Side effects, dosing, and results from completed trials.
Tremelimumab
Tremelimumab clinical trials: 234 studies for Hepatocellular Carcinoma and Colorectal Cancer, 40 recruiting. Side effects, dosing, and results from completed...
Daratumumab
Daratumumab clinical trials: 347 studies for Multiple Myeloma and Plasma Cell Myeloma, 85 recruiting. Side effects, dosing, and results from completed trials.
Ibrutinib
Ibrutinib clinical trials: 352 studies for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma, 39 recruiting. Side effects, dosing, and results from compl...
Olaparib
Olaparib clinical trials: 409 studies for Ovarian Cancer and Breast Cancer, 83 recruiting. Side effects, dosing, and results from completed trials.
Durvalumab
Durvalumab clinical trials: 732 studies for Hepatocellular Carcinoma and Non-small Cell Lung Cancer, 162 recruiting. Side effects, dosing, and results from c...
APL-3007, pegcetacoplan (APL-2)
APL-3007, pegcetacoplan (APL-2) clinical trials: 1 studies for Geographic Atrophy Secondary to Age-related Macular Degeneration, 1 recruiting. Side effects, ...
Givastomig
Givastomig clinical trials: 2 studies for Solid Tumor and Metastatic Cancer, 2 recruiting. Side effects, dosing, and results from completed trials.
Pelabresib
Pelabresib clinical trials: 8 studies for Advanced Malignancies and Solid Tumor, 4 recruiting. Side effects, dosing, and results from completed trials.
Monalizumab
Monalizumab clinical trials: 21 studies for Non-small Cell Lung Cancer and Adenocarcinoma of the Esophagus, 5 recruiting. Side effects, dosing, and results f...
Tafasitamab
Tafasitamab clinical trials: 50 studies for Diffuse Large B-cell Lymphoma and Chronic Lymphocytic Leukemia, 18 recruiting. Side effects, dosing, and results ...
Furmonertinib
Furmonertinib clinical trials: 56 studies for Non-small Cell Lung Cancer and NSCLC, 22 recruiting. Side effects, dosing, and results from completed trials.
Niraparib
Niraparib clinical trials: 199 studies for Ovarian Cancer and Ovarian Neoplasms, 34 recruiting. Side effects, dosing, and results from completed trials.
Trametinib
Trametinib clinical trials: 243 studies for Melanoma and Cancer, 39 recruiting. Side effects, dosing, and results from completed trials.
lazertinib(YH25448)
lazertinib(YH25448) clinical trials: 3 studies for EGFR Gene Mutation and Lung Neoplasms. Side effects, dosing, and results from completed trials.
ABBV-8736
ABBV-8736 clinical trials: 3 studies for Healthy Volunteer and Crohn's Disease, 1 recruiting. Side effects, dosing, and results from completed trials.
Finerenone (Kerendia, BAY948862)
Finerenone (Kerendia, BAY948862) clinical trials: 4 studies for Chronic Kidney Disease and Type 2 Diabetes Mellitus. Side effects, dosing, and results from c...
Efinopegdutide
Efinopegdutide clinical trials: 7 studies for Non-alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease. Side effects, dosing, and results from ...
Avutometinib
Avutometinib clinical trials: 21 studies for KRAS Activating Mutation and Non Small Cell Lung Cancer, 12 recruiting. Side effects, dosing, and results from c...
Mosunetuzumab
Mosunetuzumab clinical trials: 54 studies for Follicular Lymphoma and Non-Hodgkin Lymphoma, 31 recruiting. Side effects, dosing, and results from completed t...
Dabrafenib
Dabrafenib clinical trials: 147 studies for Melanoma and Metastatic Melanoma, 27 recruiting. Side effects, dosing, and results from completed trials.
Navlimetostat
Navlimetostat clinical trials: 2 studies for Healthy Participants and Non-Small Cell Lung Cancer, 1 recruiting. Side effects, dosing, and results from comple...
Avacopan
Avacopan clinical trials: 15 studies for Acne Inversa and ANCA-Associated Vasculitis, 6 recruiting. Side effects, dosing, and results from completed trials.
Zibotentan
Zibotentan clinical trials: 18 studies for Liver Cirrhosis and Chronic Kidney Disease, 1 recruiting. Side effects, dosing, and results from completed trials.
Nemtabrutinib
Nemtabrutinib clinical trials: 21 studies for Chronic Lymphocytic Leukemia and Healthy, 7 recruiting. Side effects, dosing, and results from completed trials.
Sonrotoclax
Sonrotoclax clinical trials: 24 studies for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma, 12 recruiting. Side effects, dosing, and results from comp...
Relatlimab
Relatlimab clinical trials: 90 studies for Melanoma and Metastatic Melanoma, 30 recruiting. Side effects, dosing, and results from completed trials.
Vorinostat
Vorinostat clinical trials: 272 studies for Lymphoma and Multiple Myeloma, 10 recruiting. Side effects, dosing, and results from completed trials.
TAK-279
TAK-279 clinical trials: 12 studies for Healthy Volunteers and Plaque Psoriasis, 1 recruiting. Side effects, dosing, and results from completed trials.
Savolitinib
Savolitinib clinical trials: 36 studies for Non-small Cell Lung Cancer and Carcinoma, 5 recruiting. Side effects, dosing, and results from completed trials.
Ipilimumab
Ipilimumab clinical trials: 791 studies for Melanoma and Metastatic Melanoma, 109 recruiting. Side effects, dosing, and results from completed trials.
Pegvaliase
Pegvaliase clinical trials: 8 studies for Phenylketonuria (PKU) and Phenylketonurias, 3 recruiting. Side effects, dosing, and results from completed trials.
GDC-4198
GDC-4198 clinical trials: 1 studies for Breast Cancer, 1 recruiting. Side effects, dosing, and results from completed trials.
ABBV-RGX-314 Dose 1
ABBV-RGX-314 Dose 1 clinical trials: 9 studies for Neovascular Age-related Macular Degeneration and Wet Age-related Macular Degeneration, 4 recruiting. Side ...
Cemdisiran
Cemdisiran clinical trials: 15 studies for Paroxysmal Nocturnal Hemoglobinuria and Healthy, 4 recruiting. Side effects, dosing, and results from completed tr...
Pozelimab
Pozelimab clinical trials: 18 studies for Paroxysmal Nocturnal Hemoglobinuria and CD55-deficient Protein-losing Enteropathy, 6 recruiting. Side effects, dosi...
Ropeginterferon alfa-2b
Ropeginterferon alfa-2b clinical trials: 27 studies for Polycythemia Vera and Myelofibrosis, 5 recruiting. Side effects, dosing, and results from completed t...
Defactinib
Defactinib clinical trials: 33 studies for Ovarian Cancer and Low Grade Serous Ovarian Cancer, 12 recruiting. Side effects, dosing, and results from complete...
Verteporfin
Verteporfin clinical trials: 46 studies for Macular Degeneration and Choroidal Neovascularization, 6 recruiting. Side effects, dosing, and results from compl...
Itacitinib
Itacitinib clinical trials: 50 studies for Hematologic and Lymphocytic Disorder and Solid Tumors, 3 recruiting. Side effects, dosing, and results from comple...
Deucravacitinib
Deucravacitinib clinical trials: 53 studies for Psoriasis and Plaque Psoriasis, 16 recruiting. Side effects, dosing, and results from completed trials.
Upadacitinib
Upadacitinib clinical trials: 103 studies for Atopic Dermatitis and Rheumatoid Arthritis, 33 recruiting. Side effects, dosing, and results from completed tri...
Risankizumab
Risankizumab clinical trials: 82 studies for Psoriasis and Healthy Volunteers, 12 recruiting. Side effects, dosing, and results from completed trials.
Atezolizumab
Atezolizumab clinical trials: 746 studies for Hepatocellular Carcinoma and Non-Small Cell Lung Cancer, 164 recruiting. Side effects, dosing, and results from...
Nivolumab
Nivolumab clinical trials: 1624 studies for Melanoma and Metastatic Melanoma, 273 recruiting. Side effects, dosing, and results from completed trials.
Odronextamab
Odronextamab clinical trials: 16 studies for Follicular Lymphoma (FL) and Refractory Diffuse Large B-Cell Lymphoma, 10 recruiting. Side effects, dosing, and ...
Saruparib
Saruparib clinical trials: 12 studies for Ovarian Cancer and Prostate Cancer, 10 recruiting. Side effects, dosing, and results from completed trials.
Calderasib
Calderasib clinical trials: 15 studies for Healthy and Non-small Cell Lung Cancer, 7 recruiting. Side effects, dosing, and results from completed trials.
Fianlimab
Fianlimab clinical trials: 37 studies for Melanoma and Non-small Cell Lung Cancer, 18 recruiting. Side effects, dosing, and results from completed trials.
Iberdomide
Iberdomide clinical trials: 35 studies for Multiple Myeloma and Refractory Multiple Myeloma, 19 recruiting. Side effects, dosing, and results from completed ...
Revumenib
Revumenib clinical trials: 19 studies for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, 11 recruiting. Side effects, dosing, and results from comp...
Epcoritamab
Epcoritamab clinical trials: 52 studies for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma, 28 recruiting. Side effects, dosing, and results from comp...
Glofitamab
Glofitamab clinical trials: 74 studies for Mantle Cell Lymphoma and Lymphoma, 39 recruiting. Side effects, dosing, and results from completed trials.
Elranatamab
Elranatamab clinical trials: 46 studies for Multiple Myeloma and Refractory Multiple Myeloma, 28 recruiting. Side effects, dosing, and results from completed...
Teclistamab
Teclistamab clinical trials: 50 studies for Multiple Myeloma and Refractory Multiple Myeloma, 26 recruiting. Side effects, dosing, and results from completed...
Talquetamab
Talquetamab clinical trials: 36 studies for Multiple Myeloma and Relapsed or Refractory Multiple Myeloma, 18 recruiting. Side effects, dosing, and results fr...
Tarlatamab
Tarlatamab clinical trials: 32 studies for Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer, 17 recruiting. Side effects, dosing, and result...
EYP-1901
EYP-1901 clinical trials: 8 studies for Diabetic Macular Edema and Wet Age Related Macular Degeneration, 2 recruiting. Side effects, dosing, and results from...
Lurbinectedin
Lurbinectedin clinical trials: 54 studies for Small Cell Lung Cancer and Advanced Solid Tumor, 15 recruiting. Side effects, dosing, and results from complete...
Solbinsiran
Solbinsiran clinical trials: 1 studies for Severe Hypertriglyceridemia, 1 recruiting. Side effects, dosing, and results from completed trials.
Tovecimig
Tovecimig clinical trials: 1 studies for Colorectal Cancer and Metastatic Colorectal Cancer. Side effects, dosing, and results from completed trials.
TU2218
TU2218 clinical trials: 2 studies for Advanced Solid Tumor and Biliary Tract Cancer, 2 recruiting. Side effects, dosing, and results from completed trials.
NIO752
NIO752 clinical trials: 2 studies for Alzheimer Disease and Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder), 1 r...
BHV-1400
BHV-1400 clinical trials: 2 studies for IgA Nephropathy, 1 recruiting. Side effects, dosing, and results from completed trials.
NGM120
NGM120 clinical trials: 3 studies for Colorectal Cancer and Cachexia, 1 recruiting. Side effects, dosing, and results from completed trials.
INBRX-106
INBRX-106 clinical trials: 3 studies for Gastric Cancer and Head and Neck Cancer, 1 recruiting. Side effects, dosing, and results from completed trials.
Elismetrep
Elismetrep clinical trials: 3 studies for Acute Migraine and Migraine, 1 recruiting. Side effects, dosing, and results from completed trials.
HRS-9813
HRS-9813 clinical trials: 5 studies for Pulmonary Fibrosis and Healthy Volunteers, 2 recruiting. Side effects, dosing, and results from completed trials.
SAR441566
SAR441566 clinical trials: 7 studies for Rheumatoid Arthritis and Psoriasis, 2 recruiting. Side effects, dosing, and results from completed trials.
Trientine
Trientine clinical trials: 11 studies for Wilson Disease and Diabetic Retinopathy. Side effects, dosing, and results from completed trials.
Zongertinib
Zongertinib clinical trials: 16 studies for Healthy and Lung Cancer, Non-squamous, Non-small Cell, 5 recruiting. Side effects, dosing, and results from compl...
Mirdametinib
Mirdametinib clinical trials: 20 studies for Healthy and Advanced Unresectable Melanoma, 12 recruiting. Side effects, dosing, and results from completed trials.
Relacorilant
Relacorilant clinical trials: 20 studies for Healthy and Cushing Syndrome, 3 recruiting. Side effects, dosing, and results from completed trials.
Enobosarm
Enobosarm clinical trials: 6 studies for Metastatic Breast Cancer and Estrogen Receptor Negative, 1 recruiting. Side effects, dosing, and results from comple...
daraxonrasib
daraxonrasib clinical trials: 8 studies for PDAC and Pancreatic Cancer, 6 recruiting. Side effects, dosing, and results from completed trials.
Emavusertib
Emavusertib clinical trials: 9 studies for Myelodysplastic Syndrome and Acute Myeloid Leukemia, 6 recruiting. Side effects, dosing, and results from complete...
Pumitamig
Pumitamig clinical trials: 17 studies for Advanced Solid Tumor and Non-small Cell Lung Cancer, 15 recruiting. Side effects, dosing, and results from complete...
Fostamatinib
Fostamatinib clinical trials: 62 studies for Rheumatoid Arthritis and Pharmacokinetics, 5 recruiting. Side effects, dosing, and results from completed trials.
Ranibizumab
Ranibizumab clinical trials: 480 studies for Diabetic Macular Edema and Macular Edema, 11 recruiting. Side effects, dosing, and results from completed trials.
Venetoclax
Venetoclax clinical trials: 686 studies for Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, 259 recruiting. Side effects, dosing, and results from c...
Rituximab
Rituximab clinical trials: 2053 studies for Lymphoma and Chronic Lymphocytic Leukemia, 264 recruiting. Side effects, dosing, and results from completed trials.